Colgate-Palmolive (NYSE:CL), a global leader in consumer products with a "GOOD" InvestingPro Financial Health score of 2.73, finds itself at a crossroads as it navigates a complex market environment.

In a report released today, Mark Astrachan from Stifel Nicolaus maintained a Hold rating on Colgate-Palmolive (CL – Research Report), with a price target of $93.00. The company’s shares closed ...

Raymond James lowered the firm’s price target on Colgate-Palmolive (CL) to $105 from $110 and keeps an Outperform rating on the shares. The ...

Colgate-Palmolive is down 4.3% since the beginning of the year, and at $86.70 per share, it is trading 20.3% below its 52-week high of $108.77 from September 2024.

Toothpaste and toothbrush giant Colgate-Palmolive hit a full-year revenue milestone in 2024 Colgate-Palmolive Co. shares are down 4.9% Friday despite the toothpaste and toothbrush giant reporting ...

Colgate-Palmolive Co. shares are down 4.9% Friday despite the toothpaste and toothbrush giant reporting better-than-expected fourth-quarter profit and hitting a full-year revenue milestone.

Colgate-Palmolive Co. shares are down 4.9% Friday despite the toothpaste and toothbrush giant reporting better-than-expected ...

Colgate-Palmolive's adjusted EPS reached $0.91, exceeding analyst expectations of $0.89. Revenue fell slightly short at $4.944 billion compared to the $4.98 billion estimate. The company ...

Consumer goods manufacturer Colgate-Palmolive (NYSE:CL) reported mixed fourth-quarter and full-year 2024 earnings on Friday, Jan. 31. Adjusted earnings per share (EPS) for Q4 rose to $0.91 ...

Shares of Colgate-Palmolive (NYSE: CL) pulled back today after the household products giant missed the mark on the top line in its fourth-quarter earnings report and gave a weak outlook.

Colgate-Palmolive (CL) came out with quarterly earnings of $0.91 per share, beating the Zacks Consensus Estimate of $0.89 per share. This compares to earnings of $0.87 per share a year ago.